Atlas Trials

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Clinical trial NCT04785287 · TERMINATED

Trial details

NCT number
NCT04785287
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland NeoplasmMetastatic Liver CarcinomaMetastatic Lung CarcinomaMetastatic Malignant Solid NeoplasmStage III Liver CancerStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Liver Cancer
Start date
2021-03-29
Primary completion
2026-02-26
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.